Patents Represented by Attorney, Agent or Law Firm Finnegan, Henderson, Farabow, Garret & Dunner, L.L.P.
  • Patent number: 5745282
    Abstract: A light modulation device includes a lithium niobate light modulator, an amplifier, and a bias control circuit. The lithium niobate light modulator modulates light from a light source in accordance with an input electrical signal, and outputs the modulated light. The lithium niobate light modulator includes a terminal for terminating the electrical signal. The amplifier amplifies the electrical signal to a level where it can drive the lithium niobate light modulator, and outputs the amplified signal to the lithium niobate light modulator. The amplifier includes an amplifying element at an output stage. A bias voltage of the amplifying element is set by externally supplied DC voltages. The bias control circuit supplies the DC voltages to the amplifying element, and a DC operating voltage to the terminating terminal of the lithium niobate light modulator to set a modulation operating point of the lithium niobate light modulator.
    Type: Grant
    Filed: March 26, 1996
    Date of Patent: April 28, 1998
    Assignee: Ando Electric Co., Ltd.
    Inventor: Keiji Negi
  • Patent number: 5690945
    Abstract: A cosmetic skin-cleansing mask composition which contains, as its principal cleansing constituent, graded or calibrated spheroidal polyamide particles which are dispersed in an aqueous gel, the particles being present in an amount greater than or equal to 12% by weight relative to the total weight of the composition.These particles impart to the composition a texture and qualities which are close to those of a cream.
    Type: Grant
    Filed: March 24, 1995
    Date of Patent: November 25, 1997
    Assignee: L'Oreal
    Inventors: Lien Bui-Bertrand, Nathalie Louvet-Plaisant
  • Patent number: 5612343
    Abstract: Heteroarylpiperidines, pyrrolidines, and piperazines are useful as antipsychotic and analgesic agents. the compounds are especially useful for treating psychoses by administering to a mammal a psychoses-treating effective amount of one of the compounds. Depot derivatives of the compounds are useful for providing long acting effects of the compounds. The compounds are also useful as analgesics by administering a pain-relieving effective amount of one of the compounds to a mammal.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: March 18, 1997
    Assignee: Hoechst Marion Roussel, Inc.
    Inventors: Edward J. Glamkowski, Yulin Chiang